UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000000913 |
|---|---|
| Receipt number | R000001102 |
| Scientific Title | Randomized phase II trial of Carboplatin/Gemcitabine versus Cisplatin/Gemcitabine for the patient with completely resected pathological stage IB-IIIA of Non Small Cell Lung Cancer |
| Date of disclosure of the study information | 2007/11/29 |
| Last modified on | 2019/06/11 17:54:32 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2007/11/29 21:22:30 | ||
| 2 | Update | 2007/11/29 21:27:01 | Date of disclosure of the study information |
|
| 3 | Update | 2008/05/30 09:15:32 | Email1 |
|
| 4 | Update | 2008/12/09 19:36:47 | Key inclusion criteria |
|
| 5 | Update | 2012/11/29 14:55:02 | Recruitment status Last follow-up date |
|
| 6 | Update | 2019/06/11 17:48:20 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Organization Division name Address Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization Organization Address Address Tel |
|
| 7 | Update | 2019/06/11 17:54:32 | Recruitment status Date of IRB |
